MMR deficiency was associated with poor outcome only when p53 aberrant and polymerase-ε mutant tumors were excluded from the MMR proficient subgroup, in accordance with molecular classification based on The Cancer Genome Atlas. Here, TP53 is linked to hyperinsulinemic hypoglycemia, familial, 4.